Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8500
-0.0100 (-1.16%)
Last updated: Jul 16, 2025
Epigenomics AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -3.35 | -4.46 | -17.3 | -2.43 | -11.69 | Upgrade |
Depreciation & Amortization | 0.01 | 1.35 | 7.02 | 0.34 | 0.34 | Upgrade |
Other Amortization | - | - | - | 0.08 | 0.19 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0 | - | 0.01 | - | Upgrade |
Loss (Gain) From Sale of Investments | 2.28 | - | - | - | - | Upgrade |
Stock-Based Compensation | - | - | - | 0.1 | 0.63 | Upgrade |
Other Operating Activities | 0.23 | -2.63 | 1.47 | -1.26 | 0.04 | Upgrade |
Change in Accounts Receivable | - | - | - | 0.18 | -0.16 | Upgrade |
Change in Inventory | - | - | -1.86 | -0.05 | 0.19 | Upgrade |
Change in Accounts Payable | -0.47 | 0.38 | 0.25 | -1.19 | 0.42 | Upgrade |
Change in Unearned Revenue | - | - | - | -0.01 | 0.07 | Upgrade |
Change in Other Net Operating Assets | 0.1 | -0.35 | -0.2 | 0.09 | 0.39 | Upgrade |
Operating Cash Flow | -1.2 | -5.71 | -10.63 | -4.15 | -9.57 | Upgrade |
Capital Expenditures | - | - | -0.09 | -0.04 | -0.01 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.03 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | -0.05 | - | -0.01 | Upgrade |
Investment in Securities | - | -0 | - | 0.98 | - | Upgrade |
Other Investing Activities | 0.03 | 0.04 | 0.1 | 0.01 | 0.02 | Upgrade |
Investing Cash Flow | 0.03 | 0.07 | -0.04 | 0.96 | 0 | Upgrade |
Long-Term Debt Issued | - | - | - | 22 | - | Upgrade |
Total Debt Issued | - | - | - | 22 | - | Upgrade |
Long-Term Debt Repaid | - | - | - | -0.27 | -0.27 | Upgrade |
Net Debt Issued (Repaid) | - | - | - | 21.73 | -0.27 | Upgrade |
Issuance of Common Stock | - | - | - | 2.17 | 4 | Upgrade |
Repurchase of Common Stock | - | -0.05 | - | - | -0.02 | Upgrade |
Other Financing Activities | - | -0.01 | -0.45 | -2.28 | -0.73 | Upgrade |
Financing Cash Flow | - | -0.06 | -0.45 | 21.62 | 2.98 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | -0.02 | 1.06 | -0 | Upgrade |
Net Cash Flow | -1.18 | -5.7 | -11.14 | 19.48 | -6.59 | Upgrade |
Free Cash Flow | -1.2 | -5.71 | -10.71 | -4.19 | -9.58 | Upgrade |
Free Cash Flow Margin | - | -1684.66% | -1191.77% | -67.50% | -1137.89% | Upgrade |
Free Cash Flow Per Share | -1.37 | -6.69 | -13.17 | -7.47 | -33.16 | Upgrade |
Cash Interest Paid | - | - | 0.02 | 0.02 | - | Upgrade |
Cash Income Tax Paid | - | - | - | 0.02 | 0.02 | Upgrade |
Levered Free Cash Flow | -0.84 | -1.02 | -1.57 | -2.03 | -6.25 | Upgrade |
Unlevered Free Cash Flow | -0.84 | -1.02 | -1.52 | -2 | -6.22 | Upgrade |
Change in Net Working Capital | 0.15 | -0.24 | 1.07 | -0.12 | 1.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.